Abstract Retinoblastoma is a rare childhood eye cancer with a promising outcome upon early detection and treatment. The survival rate in developed countries is more than 99%. In Ethiopia, our previous published studies showed that 47% of them died from cancer....
Abstract Purpose: To compare the clinical outcomes of children with unilateral retinoblastoma (Rb) and high-risk histopathology features (HRHF) following upfront enucleation with/without adjuvant chemotherapy, and investigate cases locally considered non-HRHF but...
Abstract Purpose: To study the treatment, and outcomes of children with retinoblastoma (RB) with extraocular tumor extension (RB-EOE) and compare them with RB without extraocular tumor extension (RB-w/o-EOE). Design: Multicenter intercontinental collaborative...
Sheba Medical Center is taking action to elevate standards of eye care worldwide through a far-reaching mission in Africa and an expert-led virtual session on retinoblastoma.
Sheba Global Ophthalmology's Dr. Mattan Arazi, together with colleagues worldwide, discuss the evolving field of Global Ophthalmology in their recent article “Global Ophthalmology in the Middle East: a Task Force Proposal.” They highlight the increasing demand for eye...
ABSTRACT Purpose:Globally, disparities exist in retinoblastoma treatment outcomes between high- and low-income countries, but independent analysis of American countries is lacking. We report outcomes of American retinoblastoma patients and explore factors associated...
